China Announces Plans To Produce 3.5 Billion Vaccine Doses in 2021

March 4 , 2021 (EIRNS)—A major expansion of COVID-19 vaccine production is underway in China, now surpassing 3.5 billion doses in 2021. Further, China has decided to vaccinate 560 million of its citizens by June 30, an average of about 5 million/day. The U.S. is just now arriving at the capacity for 2.5 million/day, on its way to a 3-4 million/day level.

At a major meeting of the Chinese Center for Disease Control on March 2, decisions were made to escalate vaccinations on a vast scale. Up to now, China has targeted 52.5 million vaccinations, concentrating upon those who are most exposed to people and products coming into the country at airports, train stations, and harbors, and upon those exposed internally, such as health workers. Their testing and tracking methods have pre-empted a need to rapidly vaccinate. However, they have decided that it would undermine the efforts of neighbors, such as India, who are going for herd immunity levels of vaccination, if China were unvaccinated when their neighbors had achieved their goal. Social responsibility dictates that China should not be the weak link at that point. Health authorities were sent around the country after the March 2 meeting, to organize the vaccinations of 560 million people by June 30 and another 330 million by the end of the year.

The 3.5 billion vaccine doses will come from Sinovac Biotech, which, according to CEO Yin Weidong, is expanding to a capacity of 2 billion doses/year; CansinoBIO, which is building a new factory in Shanghai and plans on 500 million doses in 2021; and Sinopharm, which guarantees at least 1 billion doses in 2021. Previously, India has led the world, with a production schedule of 2.25 billion COVID-19 vaccines in 2021.